XASX
ALX
Market cap3.88bUSD
Oct 09, Last price
3.82AUD
1D
-0.26%
1Q
-24.06%
Jan 2017
-22.36%
IPO
484.81%
Name
Atlas Arteria Group
Chart & performance
P/E
21.40
P/S
34.70
EPS
0.18
Div yield, %
15.67%
Shrs. gr., 5y
0.03%
Rev. gr., 5y
8.88%
Revenues
160m
+10.34%
Net income
260m
-22.74%
CFO
614m
+558.80%
Dividend
Sep 23, 20260.2 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Atlas Arteria Limited specializes in the acquisition, development, and management of toll road assets. Among its key holdings is a 13.4% equity stake in Toll Road Investors Partnership II (TRIP II), the concessionaire responsible for the 22-kilometer Dulles Greenway toll road, situated in Virginia, United States. The company was established in 2009 and operates from its corporate headquarters in Melbourne, Australia. It formally rebranded from Macquarie Atlas Roads Limited to its current name, Atlas Arteria Limited, in May 2018.
Key people
Nadine Lennie
Chief Financial Officer · since 2018
Vincent Portal-Barrault
Chief Operating Officer · since 2019
Clayton McCormack
General Counsel and Company Secretary · since 2019
John Stuart Hugh Roberts
Non-Independent Non-Executive Director · since 2010
Christine Williams
General Counsel, Company Secretary
Non-Executive Independent Chairman of the Board · since 2015
David Bartholomew
Non-Executive Independent Director · since 2018
Debra Goodin
Non-Executive Independent Director · since 2017
James M. Keyes
Non-Executive Independent Director · since 2013
Jean-Georges Malcor
Non-Executive Independent Director · since 2018
Derek Stapley
Non-Executive Independent Director · since 2010
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||